Jonathan D. Ball Ph.D.

Jonathan D. Ball, Ph.D. is a shareholder with nearly 25 years of experience representing clients in intellectual property matters, with an emphasis on patent litigation and contentious Patent Office proceedings. He also has wide-ranging experience in patent portfolio management, prosecution and licensing, and helps companies develop and implement worldwide IP strategies. Dr. Ball has served as lead counsel in patent cases in Federal District Courts throughout the United States. He has litigated numerous pharmaceutical and biotechnology cases, including cases under the Hatch-Waxman Act. He also handles appeals to the Court of Appeals for the Federal Circuit.

He regularly counsels clients in a broad range of technologies, including pharmaceuticals, biotechnology, biologics, chemicals, polymers, medical devices, energy, food sciences, cosmetics and consumer products. He has experience in a variety of bio-pharmaceutical matters, including Hatch-Waxman litigation, pre-ANDA diligence, and counseling on pharmaceutical patent life cycle management.

His practice includes transactional due diligence, particularly in the life sciences area, where he has represented a variety of companies, investment funds, and venture capital and private equity groups in connection with the acquisition and valuation of IP assets.

Dr. Ball is a frequent lecturer and writer on patent law issues, and is the author of a chapter on “Patent Prosecution” in Mathew Bender’s Intellectual Property Counseling & Litigation.

He holds a Ph.D. in organic chemistry from the University of North Carolina, Chapel Hill and was a post-doctoral researcher in the Department of Chemistry at Indiana University.

Concentrations

•Patent litigation
•Patent licensing
•Patent prosecution
•IP due diligence
•Patent opinions and counseling
•ANDA Hatch-Waxman litigation
•Post-issuance patent proceedings, including inter partes review

Recognition & Leadership

Awards & Accolades

•Listed, Patexia, ANDA Litigation Intelligence Top 100, 2024
•Listed, The Legal 500 United States
•Healthcare Life Sciences, 2024-2025
•Intellectual Property Trademarks: Litigation, 2025
•Intellectual Property Patents: Litigation (International Trade Commission), 2024
•Listed, The Best Lawyers in America, Litigation - Patent, 2024-2026
•Listed, Managing IP Magazine's World IP Handbook and Survey, 'IP Stars: Patent Stars,' 2017-2025
•Listed, IAM magazine, 'IAM Patent 1000,' 2015-2025
•Prosecution, 2015-2025
•Litigation, 2021-2025
•Listed, LMG Life Sciences, “Life Science Stars,' 2017-2025
•Listed, Super Lawyers magazine, New York Super Lawyers, 'Rising Stars,' 2013